KEI-NIH-T-Cure-Biosciences22Oct2024
Knowledge Ecology International (KEI) objects to the “Prospective Grant of an Exclusive Patent License: Anti-KK-LC-1 T Cell Receptors” (89 FR 81089) to T-Cure Biosciences, Inc. (T-Cure). Among other things, KEI said the NIH needs to be more forthcoming in the information it shares with the public when requesting comments on an exclusive license, and that it seems unlikely that an exclusive license is justified or that it would meet the legal standard set out in 35 U.S.C. § 209, given the role of the federal government in funding the development of the treatment through clinical trials.
. . .